There’s good news on the breast cancer front: Advances in medicine are helping more women than ever survive a breast cancer diagnosis.

Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UC San Francisco researcher.

The ideal interval for breast cancer screening depends on combined assessments of each woman’s breast cancer risk and her breast density, according to a new study led by UC San Francisco and University of Wisconsin (UW) researchers. The research team, members of two nationwide breast ...

Karla Kerlikowske, MD, a co-principal investigator of the Breast Cancer Surveillance Consortium(BCSC), is part of the team awarded $7.5 million by the Patient-Centered Outcomes Research Institute(PCORI) board of governors to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies.

Cancer specialists from UC San Francisco will share information on advances in research during the annual meeting of the American Society of Clinical Oncology (ASCO), one of the world’s most prestigious gatherings of oncology professionals.

Time magazine has named internationally renowned breast cancer oncologist Laura Esserman, MD, MBA, to the2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world.